Ligand Pharmaceuticals Incorporated (LGNZZ) Financial Statements (2026 and earlier)

Company Profile

Business Address 3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments733,521256,165170,309211,870341,108411,186
Cash and cash equivalent174,92772,30722,95445,00619,52247,619
Short-term investments558,594183,858147,355166,864321,586363,567
Restricted cash and investments      
Receivables61,04742,44939,31235,03891,64659,064
Inventory, net of allowances, customer advances and progress billings9,12614,11423,96913,29427,32626,487
Inventory9,12614,11423,96913,29427,32626,487
Prepaid expense  1,9341,182   
Derivative instruments and hedges, assets      
Other current assets5,78516,8972,6573,3994,6713,822
Other undisclosed current assets22,792     
Total current assets:832,271331,559237,429263,601464,751500,559
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  2,7663,3934,09516,20715,842
Operating lease, right-of-use asset  6,9076,06210,91416,5426,892
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization  15,13315,60712,48220,51114,434
Long-term investments and receivables46,500 12,595   
Long-term investments46,500 12,595   
Intangible asset, including goodwill, after accumulated amortization326,979371,898402,976448,128732,246784,992
Goodwill101,541105,250103,370105,673181,206189,662
Intangible asset, excluding goodwill, after accumulated amortization225,438266,648299,606342,455551,040595,330
Derivative instruments and hedges15,63210,583    
Deferred income tax assets8,345722148,53034,48224,320
Other noncurrent assets12,5826,9245,9234,7362,7414,267
Other undisclosed noncurrent assets318,328195,932103,01710,18210,11010,979
Total noncurrent assets:728,366610,215549,787499,067832,839861,726
TOTAL ASSETS:1,560,637941,774787,216762,6681,297,5901,362,285
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,69133,13914,89420,98825,98222,314
Accounts payable3,2385,2332,4275,3078,4033,784
Accrued liabilities31,45327,90612,46715,68117,57918,530
Deferred revenue  1,2781,22235510,99629,435
Debt 2424776,740466,593
Other liabilities135     
Other undisclosed current liabilities2,5972,6716597274,64141,769
Total current liabilities:37,44737,11216,78298,81041,665100,111
Noncurrent Liabilities
Long-term debt and lease obligation446,21849195336,269448,048
Long-term debt, excluding current maturities446,192   320,717442,293
Finance lease, liability 264919558112
Liabilities, other than long-term debt56,85270,74866,57962,91790,07295,464
Deferred revenue  2,2461,444   
Deferred income tax liabilities36,01932,52431,62230,61559,09564,598
Other liabilities16,62930,16327,75821,96630,97730,866
Operating lease, liability4,2045,8155,75510,33615,4945,643
Other undisclosed noncurrent liabilities2,9083,4262,9233,4518,4259,137
Total noncurrent liabilities:505,97874,22369,52166,373434,766552,649
Total liabilities:543,425111,33586,303165,183476,431652,760
Equity
Equity, attributable to parent1,017,212830,439700,913597,485821,159709,525
Common stock202018171716
Additional paid in capital400,649337,377198,696147,590372,969318,358
Accumulated other comprehensive income (loss)8,455(5,942)(817)(984)(917)(801)
Retained earnings608,088498,984503,016450,862449,090391,952
Total equity:1,017,212830,439700,913597,485821,159709,525
TOTAL LIABILITIES AND EQUITY:1,560,637941,774787,216762,6681,297,5901,362,285

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues268,087167,133131,314196,245277,133186,419
Cost of revenue
(Cost of Product and Service Sold)		(32,708)(200)(200)(1,100)(47,167)(23,442)
Gross profit:235,379166,933131,114195,145229,966162,977
Operating expenses(227,085)(189,739)(119,372)(193,208)(198,238)(177,688)
Other undisclosed operating income32,7082002001,10047,16740,556
Operating income (loss):41,002(22,606)11,9423,03778,89525,845
Nonoperating income (expense)117,95825,12451,71832,974(31,597)(36,383)
Investment income, nonoperating32,09283,07954,07630,586(3,111)(8,855)
Other nonoperating income (expense)(89)(54,918)(1,952)4,187(8,860)(108)
Interest and debt expense(4,715)(3,037)(656)4,192(7,303)(27,420)
Other undisclosed income from continuing operations before equity method investments, income taxes      27,420
Income (loss) from continuing operations before equity method investments, income taxes:154,245(519)63,00440,20339,995(10,538)
Other undisclosed income (loss) from continuing operations before income taxes4,7153,037656(4,192)7,303 
Income (loss) from continuing operations before income taxes:158,9602,51863,66036,01147,298(10,538)
Income tax expense (benefit)(34,507)(6,550)(9,841)(41,230)9,8407,553
Income (loss) from continuing operations:124,453(4,032)53,819(5,219)57,138(2,985)
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕57,138(2,985)
Other undisclosed net loss    (28,142)  
Net income (loss):124,453(4,032)53,819(33,361)57,138(2,985)
Other undisclosed net loss attributable to parent   (1,665)   
Net income (loss) available to common stockholders, diluted:124,453(4,032)52,154(33,361)57,138(2,985)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):124,453(4,032)53,819(33,361)57,138(2,985)
Comprehensive income (loss):124,453(4,032)53,819(33,361)57,138(2,985)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent14,397(5,125)(1,498)(67)(116)(585)
Comprehensive income (loss), net of tax, attributable to parent:138,850(9,157)52,321(33,428)57,022(3,570)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: